Abstract
BACKGROUND. The article describes the results of a clinical study of rTMS in children with migraine. PURPOSE. To study the efficacy and safety of rTMS in children and adolescents with migraine. METHODS. A prospective open-label cohort clinical study was conducted on pediatric patients with episodic and chronic migraine at Children's City Polyclinic No. 39 in Moscow. The study included 41 patients (mean age 12.34±3.42). In the first stage, we used rTMS of the left primary motor cortex with 70% of the individual motor threshold, 10 Hz (6 sec train, 45 sec inter-train interval), 600 stimuli total, 3 procedures per course. If the control parameters of effectiveness were not reached within 1 month, the patients were transferred to the 2nd stage: 10 daily procedures, 10 Hz, 70% of the individual motor threshold (4 sec train, 11 sec inter-train interval; 3000 stimuli total). RESULTS. During the 1st stage of treatment, 21.9% of patients achieved the efficacy parameters. During the 2nd stage, a significant positive trend was observed in the intensity and frequency of headache (p0.001 and p0.001): the proportion of patients who experienced a 50% or more reduction in pain intensity was 28%; the proportion of patients who experienced a 30% or more reduction of headache episodes per month was 100%. After rTMS course, HADS subscale score of depression was 41.7% (p0.001); on the Spielberger-Khanin scale, there was a significant decrease of 5,8-7.6 points (p0.001); significantly positive dynamics on the CPAQ-R by 5.2% (p=0.003) and PedsQL by 11.9% (p0.001). CONCLUSION. Repetitive TMS reduces number of episodes and intensity of migraine headaches in children, reduces symptoms of anxiety, depression, has positive effect on quality of life and functional nervous system indicators, characterized by safety and good tolerability. Increasing the stimuli number and procedures increases effectiveness and proportion of patients with a successful outcome.

This publication has 32 references indexed in Scilit: